TRAMAZOLINE
UNII SLE31693IV

Substance Identification & Data

This profile provides standardized clinical and technical data for Tramazoline, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SLE31693IV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1082-57-1 and the RxNorm Concept ID (RxCUI) 38453. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

SLE31693IV

CAS Registry Number

1082-57-1

RxNorm Concept ID

38453

Detailed Substance Profile

Preferred Name

TRAMAZOLINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C13H17N3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QQJLHRRUATVHED-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C87582

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

5524

Unique identification number in the NCBI database of chemical substances.

INN ID

1831

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1CCc2c(C1)cccc2NC3=NCCN3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tramazoline. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.